a trend towards significanceP = 0.06
The increased risk of atrial fibrillation related to treatment with IPE is consistent with the findings from other trials of omega-3 therapies [ 59 ] and there was a trend towards significance in increased serious bleeding events in those assigned to IPE compared to control (2.7 % vs 2.1 %; P = 0.06).